[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Antibacterial Drug Resistance Sales Market Report 2017

January 2017 | 122 pages | ID: G0D293E197AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antibacterial Drug Resistance

Revenue, means the sales value of Antibacterial Drug Resistance

This report studies sales (consumption) of Antibacterial Drug Resistance in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • AAIPharma Services
  • ANTABIO
  • Abgentis
  • Abbott Laboratories
  • Absynth Biologics
  • Achaogen
  • Acino Holdings
  • Aventis Pharma
  • Austell Laboratories
  • Assembly Biosciences
  • Arpida
  • Demuris
  • Evolva Holding
  • ContraFect
  • Cerexa
  • GSK
  • InterMune
  • Isis Pharmaceuticals
  • Lyndra
  • Microbecide
  • Morphochem
  • Nabriva Therapeutics
  • NanoSafe Coatings
  • Novexel
  • Osel
  • PENDOPHARM
  • Pfizer
  • VenatoRx Pharmaceuticals
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antibacterial Drug Resistance in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Telavancin (Vibativ?)
  • Ceftaroline Fosamil (Teflaro? / Zinforo)
  • Fidaxomicin (Dificid / Dificlir?)
  • Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
  • Dalbavancin (Dalvance? / Xydalba?)
  • Tedizolid Phosphate (Sivextro?)
  • Oritavancin (Orbactiv? / Nuvocid?)
  • Ceftolozane-Tazobactam (Zerbaxa?)
  • Ceftazidime-Avibactam (Avycaz? / Zavicefta)
  • PHASE III DRUGS
Split by applications, this report focuses on sales, market share and growth rate of Antibacterial Drug Resistance in each application, can be divided into
  • Gram-Positive
  • Gram-Negative
Global Antibacterial Drug Resistance Sales Market Report 2017

1 ANTIBACTERIAL DRUG RESISTANCE OVERVIEW

1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance
  1.2.1 Telavancin (Vibativ?)
  1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  1.2.3 Fidaxomicin (Dificid / Dificlir?)
  1.2.4 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
  1.2.5 Dalbavancin (Dalvance? / Xydalba?)
  1.2.6 Tedizolid Phosphate (Sivextro?)
  1.2.7 Oritavancin (Orbactiv? / Nuvocid?)
  1.2.8 Ceftolozane-Tazobactam (Zerbaxa?)
  1.2.9 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
  1.2.10 PHASE III DRUGS
1.3 Application of Antibacterial Drug Resistance
  1.3.1 Gram-Positive
  1.3.2 Gram-Negative
1.4 Antibacterial Drug Resistance Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antibacterial Drug Resistance (2012-2022)
  1.5.1 Global Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
  1.5.2 Global Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 GLOBAL ANTIBACTERIAL DRUG RESISTANCE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antibacterial Drug Resistance Market Competition by Manufacturers
  2.1.1 Global Antibacterial Drug Resistance Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Antibacterial Drug Resistance Revenue and Share by Manufacturers (2012-2017)
2.2 Global Antibacterial Drug Resistance (Volume and Value) by Type
  2.2.1 Global Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
  2.2.2 Global Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
2.3 Global Antibacterial Drug Resistance (Volume and Value) by Regions
  2.3.1 Global Antibacterial Drug Resistance Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Antibacterial Drug Resistance Revenue and Market Share by Regions (2012-2017)
2.4 Global Antibacterial Drug Resistance (Volume) by Application

3 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Antibacterial Drug Resistance Sales and Value (2012-2017)
  3.1.1 United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.1.2 United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  3.1.3 United States Antibacterial Drug Resistance Sales Price Trend (2012-2017)
3.2 United States Antibacterial Drug Resistance Sales and Market Share by Manufacturers
3.3 United States Antibacterial Drug Resistance Sales and Market Share by Type
3.4 United States Antibacterial Drug Resistance Sales and Market Share by Application

4 CHINA ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

4.1 China Antibacterial Drug Resistance Sales and Value (2012-2017)
  4.1.1 China Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  4.1.2 China Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  4.1.3 China Antibacterial Drug Resistance Sales Price Trend (2012-2017)
4.2 China Antibacterial Drug Resistance Sales and Market Share by Manufacturers
4.3 China Antibacterial Drug Resistance Sales and Market Share by Type
4.4 China Antibacterial Drug Resistance Sales and Market Share by Application

5 EUROPE ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Antibacterial Drug Resistance Sales and Value (2012-2017)
  5.1.1 Europe Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  5.1.2 Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Antibacterial Drug Resistance Sales Price Trend (2012-2017)
5.2 Europe Antibacterial Drug Resistance Sales and Market Share by Manufacturers
5.3 Europe Antibacterial Drug Resistance Sales and Market Share by Type
5.4 Europe Antibacterial Drug Resistance Sales and Market Share by Application

6 JAPAN ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Antibacterial Drug Resistance Sales and Value (2012-2017)
  6.1.1 Japan Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  6.1.2 Japan Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Antibacterial Drug Resistance Sales Price Trend (2012-2017)
6.2 Japan Antibacterial Drug Resistance Sales and Market Share by Manufacturers
6.3 Japan Antibacterial Drug Resistance Sales and Market Share by Type
6.4 Japan Antibacterial Drug Resistance Sales and Market Share by Application

7 SOUTHEAST ASIA ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Antibacterial Drug Resistance Sales and Value (2012-2017)
  7.1.1 Southeast Asia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
7.2 Southeast Asia Antibacterial Drug Resistance Sales and Market Share by Manufacturers
7.3 Southeast Asia Antibacterial Drug Resistance Sales and Market Share by Type
7.4 Southeast Asia Antibacterial Drug Resistance Sales and Market Share by Application

8 INDIA ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE)

8.1 India Antibacterial Drug Resistance Sales and Value (2012-2017)
  8.1.1 India Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  8.1.2 India Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
  8.1.3 India Antibacterial Drug Resistance Sales Price Trend (2012-2017)
8.2 India Antibacterial Drug Resistance Sales and Market Share by Manufacturers
8.3 India Antibacterial Drug Resistance Sales and Market Share by Type
8.4 India Antibacterial Drug Resistance Sales and Market Share by Application

9 GLOBAL ANTIBACTERIAL DRUG RESISTANCE MANUFACTURERS ANALYSIS

9.1 AAIPharma Services
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.1.2.1 Telavancin (Vibativ?)
    9.1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 ANTABIO
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.2.2.1 Telavancin (Vibativ?)
    9.2.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Abgentis
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.3.2.1 Telavancin (Vibativ?)
    9.3.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Abbott Laboratories
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.4.2.1 Telavancin (Vibativ?)
    9.4.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Absynth Biologics
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.5.2.1 Telavancin (Vibativ?)
    9.5.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Achaogen
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.6.2.1 Telavancin (Vibativ?)
    9.6.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Acino Holdings
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.7.2.1 Telavancin (Vibativ?)
    9.7.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Aventis Pharma
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.8.2.1 Telavancin (Vibativ?)
    9.8.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Austell Laboratories
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.9.2.1 Telavancin (Vibativ?)
    9.9.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Assembly Biosciences
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
    9.10.2.1 Telavancin (Vibativ?)
    9.10.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  9.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Arpida
9.12 Demuris
9.13 Evolva Holding
9.14 ContraFect
9.15 Cerexa
9.16 GSK
9.17 InterMune
9.18 Isis Pharmaceuticals
9.19 Lyndra
9.20 Microbecide
9.21 Morphochem
9.22 Nabriva Therapeutics
9.23 NanoSafe Coatings
9.24 Novexel
9.25 Osel
9.26 PENDOPHARM
9.27 Pfizer
9.28 VenatoRx Pharmaceuticals

10 ANTIBACTERIAL DRUG RESISTANCE MAUFACTURING COST ANALYSIS

10.1 Antibacterial Drug Resistance Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Antibacterial Drug Resistance
10.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Antibacterial Drug Resistance Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ANTIBACTERIAL DRUG RESISTANCE MARKET FORECAST (2017-2022)

14.1 Global Antibacterial Drug Resistance Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Antibacterial Drug Resistance Price and Trend Forecast (2017-2022)
14.2 Global Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Antibacterial Drug Resistance Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Antibacterial Drug Resistance
Table Classification of Antibacterial Drug Resistance
Figure Global Sales Market Share of Antibacterial Drug Resistance by Type in 2015
Figure Telavancin (Vibativ?) Picture
Figure Ceftaroline Fosamil (Teflaro? / Zinforo) Picture
Figure Fidaxomicin (Dificid / Dificlir?) Picture
Figure Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?) Picture
Figure Dalbavancin (Dalvance? / Xydalba?) Picture
Figure Tedizolid Phosphate (Sivextro?) Picture
Figure Oritavancin (Orbactiv? / Nuvocid?) Picture
Figure Ceftolozane-Tazobactam (Zerbaxa?) Picture
Figure Ceftazidime-Avibactam (Avycaz? / Zavicefta) Picture
Figure PHASE III DRUGS Picture
Table Applications of Antibacterial Drug Resistance
Figure Global Sales Market Share of Antibacterial Drug Resistance by Application in 2015
Figure Gram-Positive Examples
Figure Gram-Negative Examples
Figure United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure China Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Japan Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure India Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Global Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
Figure Global Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Table Global Antibacterial Drug Resistance Sales of Key Manufacturers (2012-2017)
Table Global Antibacterial Drug Resistance Sales Share by Manufacturers (2012-2017)
Figure 2015 Antibacterial Drug Resistance Sales Share by Manufacturers
Figure 2016 Antibacterial Drug Resistance Sales Share by Manufacturers
Table Global Antibacterial Drug Resistance Revenue by Manufacturers (2012-2017)
Table Global Antibacterial Drug Resistance Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Antibacterial Drug Resistance Revenue Share by Manufacturers
Table 2016 Global Antibacterial Drug Resistance Revenue Share by Manufacturers
Table Global Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
Table Global Antibacterial Drug Resistance Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Figure Global Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)
Table Global Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
Table Global Antibacterial Drug Resistance Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Figure Global Antibacterial Drug Resistance Revenue Growth Rate by Type (2012-2017)
Table Global Antibacterial Drug Resistance Sales and Market Share by Regions (2012-2017)
Table Global Antibacterial Drug Resistance Sales Share by Regions (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Regions (2012-2017)
Figure Global Antibacterial Drug Resistance Sales Growth Rate by Regions (2012-2017)
Table Global Antibacterial Drug Resistance Revenue and Market Share by Regions (2012-2017)
Table Global Antibacterial Drug Resistance Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Regions (2012-2017)
Figure Global Antibacterial Drug Resistance Revenue Growth Rate by Regions (2012-2017)
Table Global Antibacterial Drug Resistance Sales and Market Share by Application (2012-2017)
Table Global Antibacterial Drug Resistance Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Application (2012-2017)
Figure Global Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
Figure United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table United States Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table United States Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table United States Antibacterial Drug Resistance Sales by Type (2012-2017)
Table United States Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table United States Antibacterial Drug Resistance Sales by Application (2012-2017)
Table United States Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure China Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure China Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure China Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table China Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table China Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table China Antibacterial Drug Resistance Sales by Type (2012-2017)
Table China Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table China Antibacterial Drug Resistance Sales by Application (2012-2017)
Table China Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Europe Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table Europe Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table Europe Antibacterial Drug Resistance Sales by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Sales by Application (2012-2017)
Table Europe Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure Japan Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Japan Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Japan Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Japan Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table Japan Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table Japan Antibacterial Drug Resistance Sales by Type (2012-2017)
Table Japan Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table Japan Antibacterial Drug Resistance Sales by Application (2012-2017)
Table Japan Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure Southeast Asia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Southeast Asia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Sales by Type (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Sales by Application (2012-2017)
Table Southeast Asia Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure India Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure India Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure India Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table India Antibacterial Drug Resistance Sales by Manufacturers (2012-2017)
Table India Antibacterial Drug Resistance Market Share by Manufacturers (2012-2017)
Table India Antibacterial Drug Resistance Sales by Type (2012-2017)
Table India Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table India Antibacterial Drug Resistance Sales by Application (2012-2017)
Table India Antibacterial Drug Resistance Market Share by Application (2012-2017)
Table AAIPharma Services Basic Information List
Table AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Global Market Share (2012-2017)
Table ANTABIO Basic Information List
Table ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ANTABIO Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Abgentis Basic Information List
Table Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abgentis Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Absynth Biologics Basic Information List
Table Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Absynth Biologics Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Achaogen Basic Information List
Table Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Achaogen Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Acino Holdings Basic Information List
Table Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acino Holdings Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Aventis Pharma Basic Information List
Table Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aventis Pharma Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Austell Laboratories Basic Information List
Table Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Austell Laboratories Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Assembly Biosciences Basic Information List
Table Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Assembly Biosciences Antibacterial Drug Resistance Global Market Share (2012-2017)
Table Arpida Basic Information List
Table Demuris Basic Information List
Table Evolva Holding Basic Information List
Table ContraFect Basic Information List
Table Cerexa Basic Information List
Table GSK Basic Information List
Table InterMune Basic Information List
Table Isis Pharmaceuticals Basic Information List
Table Lyndra Basic Information List
Table Microbecide Basic Information List
Table Morphochem Basic Information List
Table Nabriva Therapeutics Basic Information List
Table NanoSafe Coatings Basic Information List
Table Novexel Basic Information List
Table Osel Basic Information List
Table PENDOPHARM Basic Information List
Table Pfizer Basic Information List
Table VenatoRx Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibacterial Drug Resistance
Figure Manufacturing Process Analysis of Antibacterial Drug Resistance
Figure Antibacterial Drug Resistance Industrial Chain Analysis
Table Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
Table Major Buyers of Antibacterial Drug Resistance
Table Distributors/Traders List
Figure Global Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Global Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Table Global Antibacterial Drug Resistance Sales Forecast by Regions (2017-2022)
Table Global Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
Table Global Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories